维普期刊资源整合服务平台（V6.5）

60篇 您的检索式：作者名="Schlieman"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Utility of tumor markers in determining resectability of pancreatic cancer显示文摘	Schlieman MG Ho HS Bold RJ	2003	Arch Surg2003，138，9：	1
2	Utility of tumor markers in determining resectability of pancreatic cancer显示文摘	Schlieman MG Ho HS Bold RJ	2003	Arch Surg2003，138，9：	1
3	Targeting BCL-2 overexpression in various human malignancies through NF kappa B inhibition by the proteasome inhibitor bortezomib显示文摘	FAHY BN SCHLIEMAN MG MORTENSON MM		0，，04：	1
4	Incidence, mechanism and prognostic value of activated AKT in pancreas cancer显示文摘	Schlieman MG Fahy BN Ramsamooj R	2003	BrJ Cancer2003，89，11：	1
5	Targeting BCL-2overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortesomib显示文摘	Fahy BN Schlieman MG Mortenson MM	2005	Cancer Chemother Pharmacol2005，56，1：	1
6	Incidence,mechanism and prognostic value of activated AKT in pancreas cancer显示文摘	Schlieman MG Fahy BN Ramsamooj R	2003	Br J Cancer2003，89，11：	1
7	Sched μle-dependent molec μlar effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer显示文摘	Fahy BN Schlieman MG Virudachalam S	2003	J Surg Res2003，113，1：	1
8	Incidence, mechanism and prognostic value of activated AKT in pancreas cancer显示文摘	Schlieman MG Fahy BN Ramsamooj R	2003	Br J Cancer2003，89，11：	1
9	Utility of tumor markers in determining resectability of pancreatic cancer显示文摘	Schlieman MG Ho HS Bold RJ	2003	Arch surg2003，138，9：	1
10	Incidence, mechanism and prognostic value of activated Akt in pancreas cancer 显示文摘	Schlieman MG Fahy BN Ramsamooj R	2003	Br J Cancer2003，89，11：	1
11	Incidence,mechanism and prognostic value of activated AKT in pancreas cancer显示文摘	Schlieman MG Fahy BN Ramsamooj R	2003	Br J Cancer2003，89，11：	1
12	Incidence,mechanism and prognostic value of activated Akt in pancreas cancer显示文摘	Schlieman MG Fahy BN Ramsamooj R	2003	Br J Cancer2003，89，11：	1
13	Incidence, mechanism and prognostic value of activated AKT in pancreas cancer显示文摘	Schlieman M G Fathy B N Ramsamoo J	2003	Br J Cancer2003，89，：	1
14	Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line显示文摘	Mortenson MM Schlieman MG Virudachalam S et at	2004	Cancer Chemother Pharmacol2004，54，4：	1
15	Incidence,mechanism and prognostic value of activated AKT in pancreas cancer显示文摘	Schlieman MG Fahy BN Ramsamooj R		0，，11：	1
16	Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer 显示文摘	Mortenson MM Schlieman MG Virudachalam S	2005	Lung Cancer2005，49，2：	1
17	Utility of tumormarkers in determining resectability of pancreatic cancer显示文摘	Schlieman M G Ho H S Bold R J	2003	Arch Surg2003，138，：	1
18	Incidence,mechanism and prognostic value of activated AKT in pancreas cancer显示文摘	SCHLIEMAN M G FAHY B N RAMSAMOOJ R	2003	Br J Cancer2003，89，11：	1
19	Reduction in bcl-2 levels by 26S proteasome inhibition with bortezomib is associated with in- duction of apoptosis in small cell lung cancer显示文摘	Mortenson MM Schlieman MG Virudachalam S	2005	Lung cancer2005，49，2：	1
20	Utility of tumor markers in determining respectability of pancreatic cancer 显示文摘	SCHLIEMAN MG HO HS Bold RJ	2003	Arch Surg2003，138，7：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示